Gender differences in the association between life history of body silhouettes and asthma incidence : results from the SAPALDIA cohort study by Hansen, S. et al.
Contents lists available at ScienceDirect
Respiratory Medicine: X
journal homepage: www.journals.elsevier.com/respiratory-medicine-x
Gender differences in the association between life history of body silhouettes
and asthma incidence: Results from the SAPALDIA cohort study
Sofie Hansen (Dr.)a,b,∗,1, Elisabeth Zempa,b, Robert Bettschartc, Marco Ponsd, Thierry Rochate,f,
Ayoung Jeonga,b, Dirk Keidela,b, Christian Schindlera,b, Nicole Probst-Henscha,b
a Department of Epidemiology and Public Health, Swiss Tropical and Public Health Institute, Basel, Switzerland
bUniversity of Basel, Switzerland
c Lungenpraxis, Medizinische Klinik Hirslanden, Aarau, Switzerland
d Sede Civico, Ospedale Regionale di Lugano, Lugano, Switzerland
e Division of Pulmonary Medicine, University Hospitals of Geneva, Switzerland
fHôpital du Valais (RSV) – Centre Hospitalier du Valais Romand, Wallis, Switzerland
A R T I C L E I N F O
Keywords:
Asthma
Incidence
Gender
Body silhouette
Obesity
Overweight
A B S T R A C T
Background: The association of obesity and asthma has been described in children and adults. However, whether
a different life course of weight in men and women may explain gender differences in asthma incidence, has not
been addressed.
Objectives: Using data from the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults, we
investigated the role of overweight/obesity as measured by body silhouettes at different life stages in men and
women for asthma incidence.
Methods: Our analysis included 5417 subjects who were asthma free at age 8, followed up to 2011, and had
complete covariate information. The main predictor of interest was self-reported body silhouettes at age 8,
menarche, 30, 45, menopause, and 60, and additionally changes in body silhouette number across these different
time points. Asthma incidence was defined as newly reported doctor-diagnosed asthma after the body silhouette
time point. Asthma incidence and its association with body silhouettes was analysed using sex stratified logistic
regression, adjusting for age, atopy, urbanity, smoking, parental asthma, education and study area.
Results: Men at age 60 had an increased risk of asthma incidence per unit increase in body silhouette number
(OR 1.93, 95% CI 1.13–3.30). This association was stronger in women at age 60 (OR 2.78, 95% CI 1.49–5.18)
and observed also at menopause (OR 1.35, 95% CI 1.03–1.78), as well as per unit change in body silhouette
number between age 45 – menopause (OR 1.74, 95% CI 1.15–2.63).
Conclusion: In this longitudinal study, the risk of incident asthma increased in men and women with a larger
body silhouette in late adulthood. In women, this risk appeared present between age 45 and menopause. At age
60, both men and women were at higher risk of asthma incidence per unit increase in body silhouette, the risk
being more pronounced in women. The age-related increase of obesity may underlie gender differences in
asthma incidence at higher ages.
1. Introduction
The incidence of asthma almost doubles in those who are obese [1].
Although studies have shown a steady dose-response relationship be-
tween incident asthma and increasing BMI, only few have evaluated the
interaction of sex and overweight/obesity on incident asthma [2–7].
Among those studies, many demonstrate the effect to be stronger in
women than in men [7–12], however, the difference in point estimates
between men and women is usually small, and other studies have
shown conflicting results [6,13–15].
Furthermore, to the best of our knowledge, no study has addressed
the association of life history of body weight and asthma in women and
men even though the course of overweight across life is known to differ
between men and women. This is well documented for the Swiss po-
pulation by the Swiss Health Survey [16], with a male preponderance of
overweight between the ages 20–50 years. In Europe, differences in
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overweight and obesity across countries are larger in men (ranging
between 51% and 69%) than in women (37.0% and 50.7%) [17]. There
is a more rapid increase of overweight and obesity in the early adult
years in men as compared to women, the assumption being that active
boys become inactive adults without change to their eating behaviour
[18]. Post-menopausal women, however, have twice the levels of
visceral fat compared to pre-menopausal women ([19] see Table 1) and
are at a higher risk of cardiovascular disease.
Given the gendered life-course pattern of asthma [20,21], and the
differential course of overweight across life between men and women
[16–18], it would be beneficial to investigate the life-course of over-
weight/obesity and asthma incidence in men and women. Romieu et al.
(2003) found that an increase in body silhouette between menarche and
adulthood relates to the incidence of asthma in later life in women from
the French E3N cohort study [22]. A high BMI was significantly asso-
ciated with the risk of asthma incidence, as was a change in body sil-
houette over time [22]. However, no such study exists in a general
population sample including men and women in order to investigate
the role of overweight/obesity at different life stages for asthma in-
cidence.
Making use of the on-going Swiss Cohort Study on Air Pollution and
Lung and Heart Diseases in Adults (SAPALDIA), now covering 20-years
of longitudinal observation of a general population sample aged 18–60
years in 1991, we investigated the association of body silhouettes and
asthma incidence in men and women, taking into account the history of
body silhouettes at different life stages as well as changes in body sil-
houettes over time.
2. Methods
2.1. Study design and population
The SAPALDIA study (see appendix) was initiated in 1991 in eight
geographically diverse areas in Switzerland. A total of 9651 persons
(51% female) aged 18–60 years participated in the baseline study
(SAPALDIA 1 (S1)) after having been recruited through random popu-
lation sampling. Re-assessments took place In 2002/2003 (SAPALDIA2
(S2), n= 8047) and in 2010/2011 (SAPALDIA 3 (S3), n= 6088). In S3
participants were asked to assess their body silhouettes retrospectively
from age 8 to current age (see Fig. 1a and b). The protocol and parti-
cipation rates have been described in further detail elsewhere [23,24].
This analysis includes 5417 subjects who were asthma free at age 8,
participated in S3 and had complete covariate information (see figure
S1 in online supplement). Ethical approval was obtained from the Swiss
Academy of Medical Sciences, the regional ethics committees, and
written informed consent was obtained from all participants.
2.2. Definition of asthma and asthma incidence
Doctor-diagnosed asthma was defined as a positive answer to the
questions ‘Have you ever had asthma?’ and ‘Was this confirmed by a
doctor?’ Asthma incidence was defined as reported asthma having been
diagnosed by a doctor after age 8. We additionally distinguished dif-
ferent incidence periods defined by the ages for which body silhouettes
were assessed, i.e. age 8, menarche, age 30, age 45, menopause, and age
60. Asthma incidence was defined at these six different time points so
that new-onset of asthma occurring after the age of reported body sil-
houettes could be investigated. In our statistical analysis, when in-
vestigating reported body silhouette at age 8, our outcome was new-
onset of asthma occurring after age 8. When investigating change in
Table 1
Main characteristics at baseline comparing those excluded from study population with those included, by sex.
Study population (N = 5417)* Excluded (N = 4234)** P-Value***
Male Female Male Female Male Female
N % N % N % N %
OVERALL 2614 48.3 803 51.7 2131 50.3 2103 49.6 0.98
Age < 0.01 < 0.01
≤30 591 22.6 551 19.7 451 21.2 402 19.1
30–40 1029 39.4 1173 41.9 745 35.0 783 37.2
45–60 994 38.0 1079 38.5 935 43.9 918 43.7
Smoking status age 30–45 <0.01 < 0.01
Never-smoker 1018 39.1 1512 54.2 545 28.0 929 47.4
Former-smoker 760 29.2 631 22.6 549 28.2 406 20.7
Current-smoker 825 31.7 648 23.2 852 43.7 626 31.9
Smoking status age 45–60 <0.01 < 0.01
Never-smoker 867 38.5 1375 54.7 370 27.5 708 50.0
Former-smoker 898 39.8 682 27.1 498 37.0 343 24.2
Current-smoker 489 21.7 456 18.2 478 35.5 364 25.7
Smoking status age 60 < 0.01 0.03
Never-smoker 504 38.4 892 62.1 151 28.7 365 60.1
Former-smoker 622 47.4 378 26.3 233 44.2 146 24.1
Current-smoker 187 14.2 167 11.6 143 27.1 96 15.8
Atopy 931 35.6 875 31.2 697 40.8 465 31.2 < 0.01 1.00
Parental asthma 221 8.5 326 11.6 219 10.3 231 11.0 0.03 0.50
Early-life respiratory infection 155 5.9 244 8.7 155 7.3 186 8.9 0.07 0.88
Education < 0.01 < 0.01
Low 95 3.6 263 9.4 17 6.0 39 10.1
Intermediate 1553 59.4 2004 71.5 156 55.3 267 69.0
High 966 37.0 536 19.1 109 38.7 81 20.9
Urban 1262 48.3 1360 48.5 1238 58.1 1239 58.9 < 0.01 < 0.01
* Study population: asthma free at age 8, participated in S3 and had complete covariate information.
** Excluded: having asthma ≤ age 8 or having missing covariate information.
***p-value: comparing distribution of characteristics within men and women separately. Using t-test for variable sex and age, and Fisher exact test for variables
smoking, parental asthma, early-life respiratory infection, education, and atopy.
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body silhouette from age period 8–30, then our outcome was asthma
occurring after age 30 and so on.
2.3. Body silhouettes
The main predictor of interest was self-report of body silhouette
number at specific ages, and additionally, the number of body silhou-
ette changes in men and women over time. Participants were asked to
report their body silhouette at age 8, menarche, age 30, age 45, me-
nopause, and age 60 (see Fig. 1a and b). The body silhouette images are
based on those created by Stunkard et al. (1983) and range from 1 (very
lean) to 9 (very obese) [25]. If participants were unsure of their exact
body silhouette, they could select two adjacent body silhouettes. For
our analysis, we reported body silhouette as a continuous variable,
using the average of the two selected body silhouettes when partici-
pants selected two silhouettes. Based on findings by Bulik et al. (2001)
[26] we categorized participants who chose a body silhouette of 6 or
more as being overweight and used this dichotomous variable in our
sensitivity analysis.
Additionally, in order to assess the association between change in
body silhouettes over time and asthma incidence, we created the fol-
lowing variables indicating the changes in silhouette score in men be-
tween ages 8–30, 30–45, 45–60, and in women between ages 8-me-
narche, menarche-30, 30–45, 45-menpause, menopause-60 in. For the
descriptive table (Table 2), we grouped the number of changes into a
score of the following four categories ≤0, 0, 1, 2 + following the ex-
ample of Romeieu et al. (2003) [22]. For our statistical analysis, the
number of changes in body silhouettes was used as a continuous vari-
able.
2.4. Further covariates
Smoking status was categorized as never-smoker, former-smoker
and current-smoker at S1, S2 and S3. Additionally, we created a
Fig. 1. a: Questionnaire body silhouettes women.
b: Questionnaire body silhouette men.
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smoking status variable indicating the smoking status of subjects cor-
responding to the time period of the reported body silhouettes, namely
smoking status at ages 30–45, 45–60 and at age 60.
Baseline age was categorized into 3 groups roughly 15 years apart
(< 30, 31–45, 46–60) for the descriptive table (Table 1). For the
models, baseline age was used as a continuous variable (age in years).
Atopy was defined as a positive response to the skin prick test or
Phadiatop test (Phadia, Uppsala, Sweden) at baseline. A positive skin
prick test was indicated by an adjusted mean wheal diameter of ≥3mm
to at least one of eight common allergens (grass, birch and Parietaria
pollen, house dust mite, cat and dog epithelia and the moulds Alternaria
and Cladosporium) [24,27]. The Phadiatop test, an in vitro allergy
screening test, detects the presence of specific serum IgE against 11
common aero-allergens (Cladosporium, Dermatophagoides pter-
onyssinus., Dermatophagoides farinae, cat, dog, horse, birch, timothy
grass [Phleum pratense], mugwort [Artemisia], olive, Parietaria judaica
[spreading pellitory]. The percentage binding of the phadiatop was
determined and results classified as positive or negative based on a cut-
off of 0.35 kU/L [24,27,28]. Allergically sensitized subjects with
doctor-diagnosed asthma were considered as having allergic asthma.
Education was categorized into primary education (low), secondary
or middle school education (intermediate), or having a technical or
university degree (high). For the descriptive tables and models, edu-
cation at baseline was used. Parental asthma was defined as a positive
answer to the question ‘did one or both of your parents ever have
asthma?’ The eight study areas participating in the SAPALDIA project
(Geneva, Basel, Lugano, Aarau, Wald, Payerne, Davos, and Montana)
were chosen to represent the variety of environmental conditions found
in Switzerland concerning geography, climate, degree of urbanization
and air pollution [24]. Urbanity was defined as residing in the following
study areas: Basel, Lugano, Aarau or Geneva. All of these covariates
were selected based on literature findings for an association with
asthma.
2.5. Statistical analysis
Asthma incidence and its association with selected body silhouettes
and the number of changes in body silhouette over time was analysed
using logistic regression adjusting for age (S1), atopy (S1), smoking (S1-
S3), parental asthma (S1), education (S1) and study area (S1) as de-
scribed above. Models were stratified by sex and run separately for the
given body silhouette time points (including, for women, menarche and
menopause) with asthma incidence occurring after that given time
point. Analyses were additionally stratified by atopy.
We conducted several sensitivity analyses. Firstly, in order to ad-
dress potential bias in loss to follow up, inverse probability weighting
was considered. Secondly, we ran our model using our dichotomous
overweight variable, comparing those who were overweight (body
silhouette ≥6) to those who were not (body silhouette< 6). Thirdly,
we ran our analysis additionally adjusting for physical activity since
studies have shown physical activity may be a protective factor against
new asthma development [29] and obesity [30]. Physical activity was
categorized into a binary variable comparing those reporting 150min/
week of moderate physical activity or 60min/week of vigorous physical
activity (sufficiently active) those who were reporting less than this
(insufficiently active). Finally, we ran our analysis additionally ad-
justing for occupational exposures defined as a positive answer to at
least one of the items in the question ‘At your working place, are you
currently exposed to dust, gas/smoke/aerosols/fumes/vapours?’
All analyses were conducted using Stata V.12 (StataCorp LP, College
Station, TX, USA).
3. Results
3.1. Study population
Our study population consisted of 5417 subjects who were asthma
free at age 8, participated in S3 and had complete covariate information
(see figure S1). The characteristics of our study population, and of those
excluded from our analyses, are presented in Table 1. Those excluded
from our study population were more likely to be men, older, and
smokers. Excluded men were also more likely to be atopic, report
parental asthma, low education and early respiratory infections. How-
ever, when conducting inverse probability weighting for non-partici-
pation, results remained largely unchanged (data not shown).
In our study population, men were more likely to be atopic than
women, more likely to be former or current smokers at all ages, and
more likely to have a higher educational level, whereas women tended
to report more parental asthma than men.
3.2. Body silhouettes
The reported body silhouettes in men and women at different ages
are shown in Fig. 2a and b. Overall, higher proportions of lower body
silhouettes were reported at younger than older ages. Irrespective of
age of body silhouette, we observed considerable gender differences in
the distributions of body silhouette. As for the number of changes in
body silhouettes over the time, these are presented by sex in Table 2.
More men than women reported an increase of body silhouette of 1 or
more at all ages than did women.
3.3. Asthma incidence
New-onset of asthma occurring after each body silhouette time
point is presented in table S1. New-onset of asthma was persistently
higher among women than among men, particularly up to age 30.
Table 2
Changes in body silhouette score at different age periods stratified by sex.
Men Women
Age Number of changesa Age Number of changesa
≤0 0 1 2+ ≤0 0 1 2+
n % n % n % n % n % n % n % n %
– – – – – – – – 8 - menarche 116 5.2 1019 45.9 816 36.7 270 12.2
– – – – – – – – Menarche – 30 294 13.4 746 33.9 862 39.2 296 13.5
8–30 135 6.1 311 14.1 728 33.1 1026 46.6 8–30 212 9.6 443 20.0 750 33.9 807 36.5
30–45 62 3.3 647 34.3 827 43.9 349 18.5 30–45 91 4.8 875 46.4 724 38.4 196 10.4
– – – – – – – – 45 – menopause 82 5.7 767 53.4 489 34.0 99 6.9
– – – – – – – – Menopause - 60 69 7.5 473 51.1 316 34.1 68 7.3
45–60 63 6.0 277 26.5 455 43.6 249 23.9 45–60 63 6.3 316 31.8 409 41.2 205 20.6
a Number of changes in body silhouette from one age to the next.
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3.4. Determinants of asthma incidence
When adjusting for relevant confounders, the risk of new-onset of
asthma associated with a 1 unit increase in body silhouette for men and
women is presented for men and women separately in Table 3. In men
and women, the association became statistically significant at age 60
(men OR 1.93, 95% CI 1.13–3.30), (women OR 2.78, 95% CI
1.49–5.18) and additionally, in women after menopause (OR 1.35, 95%
CI 1.03–1.78).
Women also had an increased risk of asthma incidence per 1 unit
change in body silhouette between the age 45-menopause (OR 1.74,
95% CI 1.15–2.63) (Table 4). In women, the risk of new-onset of asthma
with each unit of increasing body silhouette from menopause to age 60
was borderline significant (OR 1.97, 95% CI 1.00–3.90). We saw no
association between change in body silhouette and asthma incidence in
men.
3.5. Sensitivity analysis
When stratifying by atopic status, there was a tendency, albeit low
statistical power, for a stronger body silhouette-asthma onset associa-
tion after age 60 in non-atopic men (OR 2.34, 95% CI 1.09–5.05) and
non-atopic women (OR 4.14, 95% CI 1.39–12.38) (Table 3). In women
the OR for incident asthma after menarche was stronger in atopic
women with each unit of increase in body silhouette at menarche (OR
1.19, 95% CI 1.02–1.38) (Table 3) whereas it was stronger in non-
atopic women when looking at changes in body silhouette from me-
narche – age 30 (OR 1.25, 95% CI 1.01–1.55).
When running our analysis with our dichotomous body silhouette
variable comparing those with a body silhouette of ≥6 to those with a
body silhouette of< 6, the ORs increased in all age groups for both
body silhouettes at a specific age (Table 3) and also increase in body
silhouette changes over time (Table 4).
We ran our analysis additionally adjusting for physical activity
(table S2 and S3 online supplement). The results did not significantly
change. However, the OR for men with a higher body silhouette at age
60 became slightly larger (OR 1.83, 95% CI 1.09–3.07), as did the OR
for incident asthma after age 60 in women (OR 2.69, 95% CI 1.44–5.02)
(table S2 online supplement). When additionally adjusting for physical
activity when looking at the association between change of body sil-
houettes and incident asthma, the association with 1 unit increase in
body silhouette score in women between age 45 and menopause be-
came significant (OR 1.67, 95% CI 1.09–2.58) (table S3 online sup-
plement).
When additionally adjusting for occupational exposure, the asso-
ciation of body silhouette at different ages with asthma incidence did
not change (table S4 online supplement). Results also did not change
when looking at change in body silhouette number across different age
periods and its association with incident asthma (table S5 online sup-
plement).
4. Discussion
4.1. Main findings
A larger body silhouette later in life, but not at young ages, increases
the risk of incident asthma in men, and even more so in women. In men,
each unit increase in body silhouette at age 60 doubled the likelihood
for asthma after age 60. The likelihood for incident asthma in women
was 1.5 as likely for the body silhouette at menopause and 3 times as
likely for age 60. Change in body silhouette number over time was only
significantly associated with the likelihood of incident asthma in
women between age 45- menopause, with an almost twofold increase in
likelihood. Despite low numbers, atopic status seemed to be a mod-
ifying effect in women at menarche and menopause. The results point to
an important effect of weight on asthma at older ages and particularly
in postmenopausal women.
4.2. Comparison with other studies
Very few studies have evaluated the interaction of sex and over-
weight/obesity on newly acquired asthma, which is important given the
sex effect observed in previous studies on obesity and asthma [14,31].
Brumpton et al. (2013) prospectively explored the association of BMI
and waist circumference on asthma incidence in a Norwegian study
population aged 19–65 years old [5]. They found that BMI-derived
general overweight and obesity was a risk factor for incident asthma for
males and females, and, in addition, that waist circumference derived
abdominal obesity was a risk factor for incident asthma only in females.
Egan et al. (2014) have also used measures in addition to BMI to assess
the risk for asthma incidence but in a slightly younger Norwegian study
population (12–30 years old) [6]. They found that baseline general
overweight and abdominal obesity were significantly associated with
an increased risk of newly acquired asthma, however when stratified by
sex, this association remained significant only in men [6]. This is in
contrast to previous findings which found BMI to be associated with
incident asthma in adolescent and young females, but not in males
[2,31]. This effect, however, has been inconsistent among children,
possibly due to the differences in body fat accumulation and distribu-
tion around timing of puberty, particularly among females. Egan et al.
Fig. 2. a: Selected body silhouette* in men.
b: Selected Body Silhouette* in Women. * Body silhouette image ranging from 1
(very lean) to 9 (very obese).
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(2014) could not adjust for duration and intensity of physical activity,
nor could they differentiate between atopic and non-atopic asthma [6].
However, Beckett et al. (2001) found that gain in BMI is associated with
new asthma diagnosis in young female adults even when adjusting for
changes in physical activity [9].
In order to assess the life history of body weight, the use of body
silhouette images [25,32] offers a practical method when asking elderly
subjects to recall the distant past and childhood build [33–37] or when
measured and self-reported BMI are not available [38]. The use of body
silhouettes has been validated [36,37,39] and used in studies assessing
incident diabetes [40] and asthma incidence in women [22]. Romieu
et al. (2003) found a higher BMI to be significantly associated with the
Table 3
Association of body silhouettes at different ages and reproductive time points with new-onset of asthma, stratified by sex, atopic status & overweight.
Models OR Body Silhouette Mena OR Body Silhouette Womena
N OR (95% CI) N OR (95% CI)
Age 8e
Overall modelb 2208 1.01 (0.90–1.13) 2245 1.04 (0.94–1.14)
Dichotomous
overweight modelc
2208 1.31 (0.62–2.77) 2245 1.50 (0.65–3.49)
Stratified atopic modeld 781 1.03 (0.90–1.18) 703 1.10 (0.96–1.26)
Stratified non-atopic
modeld
1427 0.95 (0.76–1.20) 1542 0.98 (0.85–1.13)
Menarchef
Overall modelb – – 2191 1.05 (0.94–1.16)
Dichotomous
overweight modelc
– – 2191 1.25 (0.58–2.69)
Stratified atopic modeld – – 684 1.19 (1.02–1.38)
Stratified non-atopic
modeld
– – 1507 0.93 (0.79–1.08)
Age 30g
Overall modelb 2136 1.13 (0.96–1.33) 2125 1.12 (0.98–1.29)
Dichotomous
overweight modelc
2136 1.70 (0.82–3.57) 2125 1.52 (0.71–3.27)
Stratified atopic modeld 711 1.22 (0.99–1.52) 622 1.21 (0.97–1.51)
Stratified non-atopic
modeld
1425 0.98 (0.75–1.28) 1503 1.06 (0.88–1.27)
Age 45h
Overall modelb 1776 1.12 (0.90–1.39) 1752 1.12 (0.90–1.39)
Dichotomous
overweight modelc
613 4.66
(1.06–20.45)
1752 2.20 (0.95–5.13)
Stratified atopic modeld 541 1.11 (0.80–1.53) 440 1.17 (0.82–1.69)
Stratified non-atopic
modeld
1235 1.12 (0.81–1.53) 1265 1.09 (0.82–1.43)
Menopausei
Overall modelb - - 1136 1.35 (1.03–1.78)
Dichotomous
overweight modelc
- - 1136 2.22 (0.96–5.15)
Stratified atopic modeld - - 275 1.48 (0.92–2.38)
Stratified non-atopic
modeld
- - 700 1.23 (0.85–1.76)
Age 60j
Overall modelb 613 1.93 (1.13–3.30) 877 2.78 (1.49–5.18)
Dichotomous
overweight modelc
613 4.66
(1.06–20.46)
877 6.17
(1.68–22.69)
Stratified atopic modelll 130 1.40 (0.58–3.41) 124 3.27
(0.88–12.21)
Stratified non-atopic
modelll
312 2.34 (1.09–5.05) 274 4.14
(1.39–12.38)
Data are presented as odds ratios (OR) representing the increased likelihood per 1 unit increase in body silhouette number at given age or reproductive time point,
and 95% confidence intervals (CI). Bold indicates significance at p≤0.05.
a Body silhouettes men and women: selected body silhouette [1–9] (see figure S1a and S1b).
b Overall model: logistic regression stratified by sex, adjusting for body silhouette as a continuous variable, age, atopy, urbanity, smoking at the corresponding
interval of the body silhouette, parental asthma, education and study area.
c Dichotomous overweight model: overall model but using body silhouette as a dichotomous variable comparing those reporting a body silhouette ≥6 (over-
weight) to those reporting body silhouette< 6 (not overweight).
d Atopic/non-atopic model: overall model stratified by atopic status at baseline.
e Age 8: overall model using body silhouette reported at age 8 and its association with asthma occurring after 8 years age.
f Menarche: overall model investigating body silhouette reported at menarche and its association with asthma occurring after menarche.
g Age 30: overall model investigating body silhouette reported at age 30 and its association with asthma occurring after age 30.
h Age 45: overall model investigating body silhouette reported at age 45 and its association with asthma occurring after age 45.
i Menopause: overall model investigating body silhouette reported at menopause and its association with asthma occurring after menopause.
j Age 60: overall model investigating body silhouette reported at age 60 and its association with asthma occurring after age 60.
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risk of asthma incidence, and also, that an increase in body silhouette
between menarche and adulthood related to the incidence of asthma in
later life [22]. Women who gained two or more silhouette points (ap-
proximately ≥10 kg) after menarche had a 66% increased risk of
asthma when compared with women who did not change silhouette,
after adjustment for relevant confounders (multivariate RR=1.66,
95% CI 1.18, 2.23, test for trend: p < 0.001). Similarly, an 89% in-
creased risk of asthma was observed for women who gained two or
more silhouettes after the age of 20 years (multivariate RR=1.89, 95%
CI 1.37, 2.60, test for trend: p < 0.001). When they restricted the
analysis to women who had a BMI of 20–24 (“normal”) at menarche or
around 20 years of age, results remained similar, suggesting that esti-
mates were not driven by women with high BMIs who gained additional
weight [22]. The observed association between an increase in body
silhouette after menarche and adult onset of asthma in this study
somewhat contradicts our findings. In our study, body silhouette at
menopause and later was a significant predictor for asthma incidence in
women. A change of body silhouette as of age 45 was only borderline
significant in our study. But when stratifying by atopy, atopic women
with a larger body silhouette at menarche were more likely than other
women at the same age to newly develop asthma after menarche (OR
1.19, 95% CI 1.02–1.38). Perhaps this partly accounts for the highest
asthma incidence seen in young atopic women in the study by Hansen
et al. (2015) [20].
To the best of our knowledge, no study has addressed the associa-
tion of life history of body silhouettes and asthma in men, even though
the life course of overweight is known to differ between men and
women [16], as is the fat distribution [41]. In our previous study,
Table 4
Association of change in body silhouette across different age periods with new-onset of asthma, stratified by sex, atopic status & overweight.
Models OR Change Body Silhouette Mena OR Change Body Silhouette Womene
N OR (95% CI) N OR (95% CI)
Age 8-menarched
Overall modelb – – 2156 0.98 (0.83–1.14)
Stratified atopic modelc – – 675 1.08 (0.87–1.35)
Stratified non-atopic modelc – – 1481 0.87 (0.69–1.10)
Menarche- age 30ll
Overall modelb – – 2066 1.15 (0.98–1.34)
Stratified atopic modelc – – 616 1.02 (0.81–1.30)
Stratified non-atopic modelc – – 1450 1.25 (1.01–1.55)
Age 8 - age 30e
Overall modelb 2081 1.02 (0.87–1.21) – –
Stratified atopic modelc 697 1.06 (0.85–1.32) – –
Stratified non-atopic modelc 1384 0.98 (0.76–1.26) – –
Age 30 - age 45f
Overall modelb 1757 1.18 (0.87–1.59) 1722 0.92 (0.66–1.30)
Stratified atopic modelc 535 1.01 (0.64–1.57) 432 0.70 (0.37–1.34)
Stratified non-atopic modelc 1222 1.34 (0.90–1.99) 1243 1.06 (0.69–1.61)
Age 45 - menopauseg
Overall modelb - – 1086 1.74 (1.15–2.63)
Stratified atopic modelc - - 266 1.64 (0.82–3.29)
Stratified non-atopic modelc - - 658 1.83 (1.07–3.12)
Age 45 - age 60h
Overall modelb 498 1.38 (0.69–2.75) – -
Stratified atopic modelc 101 0.48 (0.17–1.35) - -
Stratified non-atopic modelc 218 2.07 (0.88–4.87) - -
Menopause – age 60i - -
Overall modelb - - 527 1.97 (1.00–3.90)
Stratified atopic modelc - - 52 329.9 (0.33–334797.9)
Stratified non-atopic modelc - - 192 1.37 (0.51–3.71)
Data are presented as odds ratios (OR) representing the increased likelihood per 1 unit change in silhouette number across the given age period, and 95% confidence
intervals (CI).
a Change body silhouettes men and women: change in selected body silhouette score [1–9] (see figure S1a and S1b).
b Overall model: logistic regression stratified by sex, adjusting for change in body silhouette as a continuous variable, age, atopy, urbanity, smoking at the
corresponding interval of the body silhouette, parental asthma, education and study area.
c Atopic/non-atopic model: overall model stratified by atopic status at baseline.
d Age 8-menarche: overall model using changes in body silhouette score between age 8 and menarche as a continuous variable and asthma incidence occurring
after menarche.
e Age 8 - age 30: overall model using changes in body silhouette score between age 8 and age 30 as a continuous variable and asthma incidence occurring after age
30.
f Age 30 - age 45: overall model using number changes in body silhouette score between age 30 and age 45 as a continuous variable and asthma incidence
occurring after age 45.
g Age 45 - menopause: overall model using changes in body silhouette score between age 45 and menopause as a continuous variable and asthma incidence
occurring after menopause.
h Age 45 - age 60: overall model using changes in body silhouette score between age 45 and age 60 as a continuous variable and asthma incidence occurring after
age 60.
i Menopause – age 60: overall model using changes in body silhouette score between menopause and age 60 as a continuous variable and asthma incidence
occurring after age 60.
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women were twice as likely as men to newly develop asthma [20]. This
association was modified by age and atopy: the highest risk of incident
asthma being in young atopic women. Gender differences were most
pronounced in non-atopic subjects and decreased with increasing age
[20]. In our current study, atopic women at menarche with a larger
body silhouette number were at increased risk for incident asthma,
which could potentially explain the high incidence of asthma in young
atopic women which we observed previously. At age 60, both men and
women were at higher risk of asthma incidence per unit increase in
body silhouette, the risk being more pronounced in women. These
findings are consistent with and support the life course pattern of in-
cident asthma we observed previously ([20] see Fig. 2a and b). The
associations of larger body silhouettes with asthma incidence in our
current study may help explain gender differences in asthma incidence.
4.3. Strengths and limitations
The Swiss Cohort on Lung and Heart Disease in Adults (SAPALDIA)
offers the unique opportunity to investigate the role of body silhouettes
from a life course perspective for men and women. In addition, with the
extensive SAPALDIA data, a number of further factors can be taken into
account, such as allergic and non-allergic asthma, as well as duration
and intensity of physical activity. And finally, strength lies in SAPAL-
DIA's large data base representing the general population of
Switzerland across urban, rural and mountainous areas with different
environmental exposure characteristics and building on standardised
measurements and a health questionnaire which was developed along
with the European Community Respiratory Health Survey (ECHRS)
[24,42].
In studies prospectively investigating the association between obe-
sity and asthma, reported sex-related differences are inconsistent [43].
It has been argued that BMI cannot distinguish between fat mass and
muscle mass [44]. Most notably, BMI has limitations in predicting ab-
dominal fat deposition, which is associated with reduced pulmonary
function, metabolic syndrome and cardiovascular complications
[45–47]. BMI may inadequately reflect fat distribution and may under-
or overestimate obesity as wide variations in body fat distribution can
occur within the same BMI percentile group [48]. BMI does not dif-
ferentiate between fat and lean body mass, and for a given BMI, females
generally have a higher proportion of body fat than males [49]. This is
where the use of body silhouettes is important and beneficial. Ab-
dominal obesity may better reflect metabolic differences in sub-
cutaneous and visceral fat deposits known to influence systemic in-
flammation.
A possible limitation of this study is the remote recall and accuracy
of self-reported body silhouettes and asthma prior to baseline. Worse
recall of body silhouettes at younger ages may have biased associations
with asthma onset during earlier years towards null. However, Must
et al. (1993) found good correlations between body silhouettes and
measured BMI for females, even when using adult silhouettes to re-
present their body sizes at age 10 and 15 years [34]. Troy et al. (1995)
reported correlation of 0.66 between BMI at age 18 years and silhou-
ettes compared with a correlation of 0.84 for actual and recalled BMI at
18 years [50] whereas Munoz et al. (1996) obtained correlations of
0.75 for BMI and silhouettes compared with 0.89 for actual and recalled
BMI [33]. As for Koprowski et al. (2001) they found that recall of body
shape at menarche was considered to be a less precise measure than
asking about weight and height, but use of body silhouettes may offer a
more practical method for obtaining information for the past [35]. And
finally, Bulik et al. (2002) found that figural stimuli are effective in
classifying individuals as obese or thin [26].
As the SAPALDIA study is prospective in nature, recall bias is un-
likely. However, since participants were 18–60 at baseline, information
on body silhouettes and asthma onset prior to this age, were collected
retrospectively. This may have biased results at age 8 towards the null.
We cannot dismiss that remote recall of self-reported asthma may have
introduced some recall bias and possibly led to insignificant odds ratios
at younger ages. However, previous studies have shown reported year
of asthma onset to be realistically accurate [51] and that variation in
reporting age at diagnosis to be low across categories of participant
characteristics such as gender [52]. Furthermore, in our previous study,
using additional asthma incidence definitions with stricter restriction
criteria on inconsistencies in the reporting of first attack of asthma did
not change results [20]. Future studies may need to prospectively assess
body silhouettes and asthma incidence from childhood in order to
better assess the association at younger ages.
5. Conclusion
According to this longitudinal study, body silhouettes matter most
for asthma onset at older ages in men and women. Additionally, in-
creasing in body silhouette number from age 45 - menopause sig-
nificantly increases the risk of incident asthma in women. Despite low
numbers, atopic status seems to be a modifying effect in women at
menarche and menopause. The increasing prevalence of obesity may
therefore lead to more asthma at higher ages in adults. Pooling data or
having future studies with an even larger study population with an
older age range may help to better understand the role of body sil-
houettes in gender differences in asthma, especially the potential
modification by atopy.
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